Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OmniAb, Inc. - Common Stock (NQ: OABI )

4.135 +0.215 (+5.48%)
Streaming Delayed Price Updated: 1:10 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 111,568
Open 3.990
Bid (Size) 4.130 (5)
Ask (Size) 4.140 (8)
Prev. Close 3.920
Today's Range 3.990 - 4.150
52wk Range 3.560 - 6.715
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
Earnings Scheduled For November 12, 2024
Via Benzinga

Performance

YTD
-33.84%
-33.84%
1 Month
+10.27%
+10.27%
3 Month
-5.59%
-5.59%
6 Month
-0.84%
-0.84%
1 Year
-4.72%
-4.72%

More News

Read More
OmniAb to Participate in Two Investor Conferences in November
From OmniAb, Inc.
Via Business Wire
OmniAb to Report Third Quarter 2024 Financial Results on November 12
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Two Investor Conferences in September
From OmniAb, Inc.
Via Business Wire
Recap: OmniAb Q4 Earnings
Via Benzinga
Earnings Preview For OmniAb
Via Benzinga
OABI Stock Earnings: OmniAb Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb to Report Second Quarter 2024 Financial Results on August 8
From OmniAb, Inc.
Via Business Wire
OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in the Jefferies Global Healthcare Conference
From OmniAb, Inc.
Via Business Wire
OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit
From OmniAb, Inc.
Via Business Wire
OABI Stock Earnings: OmniAb Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
OmniAb Reports First Quarter 2024 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Five Investor Conferences in May
From OmniAb, Inc.
Via Business Wire
OmniAb to Report First Quarter 2024 Financial Results on May 9
From OmniAb, Inc.
Via Business Wire
Over $1M Bet On OmniAb? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
OABI Stock Earnings: OmniAb Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
Earnings Scheduled For March 20, 2024
Via Benzinga
OmniAb to Report Fourth Quarter 2023 Financial Results on March 20
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Two Investor Conferences in March
From OmniAb, Inc.
Via Business Wire
Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight
Via InvestorPlace
OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference
From OmniAb, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.